The effects of GLP-1 analogues, DPP-4 inhibitors and SGLT2 inhibitors on the renal system

Diabetic nephropathy (DN) affects an estimated 20%–40% of patients with type 2 diabetes mellitus (T2DM). Key modifiable risk factors for DN are albuminuria, anaemia, dyslipidaemia, hyperglycaemia and hypertension, together with lifestyle factors, such as smoking and obesity. Early detection and trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Schernthaner, Guntram, Mogensen, Carl Erik, Schernthaner, Gerit-Holger
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2014
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4230539/
https://www.ncbi.nlm.nih.gov/pubmed/25116004
http://dx.doi.org/10.1177/1479164114542802

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4230539/
https://www.ncbi.nlm.nih.gov/pubmed/25116004
http://dx.doi.org/10.1177/1479164114542802

Ejemplares similares